POST 5-ALPHA-REDUCTASE INHIBITOR SYNDROME

This adverse event was reported 284 times

These drugs are most commonly taken by patients reporting POST 5-ALPHA-REDUCTASE INHIBITOR SYNDROME:

# Drug Count
0 FINASTERIDE 278
1 DUTASTERIDE 11
2 MINOXIDIL 10
3 MINOXIDIL FOAM 5% (WOMENS) 10
4 FLUVASTATIN 8
5 RAMIPRIL 8
6 ESCITALOPRAM 6
7 ESCITALOPRAM OXALATE 6
8 FLUOXETINE HYDROCHLORIDE 6
9 FLUOXETINE 5
See all common drugs associated with POST 5-ALPHA-REDUCTASE INHIBITOR SYNDROME

POST 5-ALPHA-REDUCTASE INHIBITOR SYNDROME is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 AVANAFIL 1 0.0143
1 FINASTERIDE 278 0.0045
2 CICLOPIROX OLAMINE 1 0.0021
3 DUTASTERIDE 11 0.0013
4 DEXTROMETHORPHAN HYDROBROMIDE, BUPROPION HYDROCHLORIDE 1 0.0003
5 DOXEPIN HYDROCHLORIDE 3 0.0002
6 MINOXIDIL 10 0.0002
7 TAMSULOSIN HYDROCHLORIDE 4 0.0002
8 BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE 1 0.0001
9 LETROZOLE TABLETS 4 0.0001
See all drugs enriched for association with POST 5-ALPHA-REDUCTASE INHIBITOR SYNDROME